On August 28, 2025 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, reported that management will participate in the following investor conferences in September (Press release, CytomX Therapeutics, AUG 28, 2025, View Source [SID1234655547]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference 2025
Date: Thursday, September 4, 2025
Fireside Chat: 8:35 a.m. ET
Location: New York, NY

H.C. Wainwright 27th Annual Global Investment Conference
Date: Tuesday, September 9, 2025
Formal Presentation: 11:30 a.m. ET
Location: New York, NY

Morgan Stanley 23rd Annual Global Healthcare Conference
Date: Wednesday, September 10, 2025
Fireside Chat: 1:05 p.m. ET
Location: New York, NY

A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conference.

On August 28, 2025 CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, reported that management will participate in the H.C. Wainwright 27th Annual Global Investment Conference being held September 8 to 10, 2025, at the Lotte New York Palace Hotel in New York City (Press release, CytoDyn, AUG 28, 2025, View Source [SID1234655546]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Robert E. Hoffman, Chief Financial Officer, will deliver a presentation on Wednesday, September 10, at 1:30 p.m. EDT, which will be accessible via webcast here, and will be available for one-on-one meetings with registered conference attendees.

On August 28, 2025 CorMedix Inc. ("CorMedix") (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, reported that senior management will be presenting and participating in investor meetings at upcoming investor conferences taking place in September (Press release, CorMedix, AUG 28, 2025, View Source [SID1234655545]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference
Date: September 5, 2025
Time: 8:35am Eastern
Format: Fireside Chat
Webcast: Link to webcast

Morgan Stanley 23rd Annual Global Healthcare Conference
Date: September 10, 2025
Time: 10:45am Eastern
Format: Fireside Chat
Webcast: Link to webcast

On August 28, 2025 CorMedix Inc. ("CorMedix") (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, reported that senior management will be presenting and participating in investor meetings at upcoming investor conferences taking place in September (Press release, CorMedix, AUG 28, 2025, View Source [SID1234655545]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference
Date: September 5, 2025
Time: 8:35am Eastern
Format: Fireside Chat
Webcast: Link to webcast

Morgan Stanley 23rd Annual Global Healthcare Conference
Date: September 10, 2025
Time: 10:45am Eastern
Format: Fireside Chat
Webcast: Link to webcast

On August 28, 2025 CorMedix Inc. ("CorMedix") (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, reported that senior management will be presenting and participating in investor meetings at upcoming investor conferences taking place in September (Press release, CorMedix, AUG 28, 2025, View Source [SID1234655545]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference
Date: September 5, 2025
Time: 8:35am Eastern
Format: Fireside Chat
Webcast: Link to webcast

Morgan Stanley 23rd Annual Global Healthcare Conference
Date: September 10, 2025
Time: 10:45am Eastern
Format: Fireside Chat
Webcast: Link to webcast